Literature DB >> 22099035

An endorectal balloon reduces intrafraction prostate motion during radiotherapy.

Robert Jan Smeenk1, Robert J W Louwe, Katja M Langen, Amish P Shah, Patrick A Kupelian, Emile N J Th van Lin, Johannes H A M Kaanders.   

Abstract

PURPOSE: To investigate the effect of endorectal balloons (ERBs) on intrafraction and interfraction prostate motion during radiotherapy. METHODS AND MATERIALS: Thirty patients were treated with intensity-modulated radiotherapy, to a total dose of 80 Gy in 40 fractions. In 15 patients, a daily-inserted air-filled ERB was applied. Prostate motion was tracked, in real-time, using an electromagnetic tracking system. Interfraction displacements, measured before each treatment, were quantified by calculating the systematic and random deviations of the center of mass of the implanted transponders. Intrafraction motion was analyzed in timeframes of 150 s, and displacements >1 mm, >3 mm, >5 mm, and >7 mm were determined in the anteroposterior, left-right, and superoinferior direction, and for the three-dimensional (3D) vector. Manual table corrections, made during treatment sessions, were retrospectively undone.
RESULTS: A total of 576 and 567 tracks have been analyzed in the no-ERB group and ERB group, respectively. Interfraction variation was not significantly different between both groups. After 600 s, 95% and 98% of the treatments were completed in the respective groups. Significantly fewer table corrections were performed during treatment fractions with ERB: 88 vs. 207 (p = 0.02). Intrafraction motion was significantly reduced with ERB. During the first 150 s, only negligible deviations were observed, but after 150 s, intrafraction deviations increased with time. This resulted in cumulative percentages of 3D-vector deviations >1 mm, >3 mm, >5 mm, and >7 mm that were 57.7%, 7.0%, 0.7%, and 0.3% in the ERB-group vs. 70.2%, 18.1%, 4.6%, and 1.4% in the no-ERB group after 600 s. The largest reductions in the ERB group were observed in the AP direction. These data suggest that a 5 mm CTV-to-PTV margin is sufficient to correct for intrafraction prostate movements when using an ERB.
CONCLUSIONS: ERB significantly reduces intrafraction prostate motion, but not interfraction variation, and may in particular be beneficial for treatment sessions longer than 150 s.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22099035     DOI: 10.1016/j.ijrobp.2011.07.028

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  34 in total

1.  Impact of different setup approaches in image-guided radiotherapy as primary treatment for prostate cancer: a study of 2940 setup deviations in 980 MVCTs.

Authors:  Kilian Schiller; Alessia Petrucci; Hans Geinitz; Tibor Schuster; Hanno Specht; Severin Kampfer; Marciana Nona Duma
Journal:  Strahlenther Onkol       Date:  2014-04-23       Impact factor: 3.621

2.  Prefraction displacement and intrafraction drift of the prostate due to perineal ultrasound probe pressure.

Authors:  Minglun Li; Nina-Sophie Hegemann; Farkhad Manapov; Anne Kolberg; Patrick Dominik Thum; Ute Ganswindt; Claus Belka; Hendrik Ballhausen
Journal:  Strahlenther Onkol       Date:  2017-02-14       Impact factor: 3.621

3.  Penile bulb sparing in prostate cancer radiotherapy : Dose analysis of an in-house MRI system to improve contouring.

Authors:  F Böckelmann; M Hammon; S Lettmaier; R Fietkau; C Bert; F Putz
Journal:  Strahlenther Onkol       Date:  2018-10-12       Impact factor: 3.621

Review 4.  Effectiveness of rectal displacement devices in managing prostate motion: a systematic review.

Authors:  Mahdieh Afkhami Ardekani; Hamed Ghaffari; Mahmoud Navaser; Seyed Hamid Zoljalali Moghaddam; Soheila Refahi
Journal:  Strahlenther Onkol       Date:  2020-05-22       Impact factor: 3.621

5.  Measurement of patient imaging dose for real-time kilovoltage x-ray intrafraction tumour position monitoring in prostate patients.

Authors:  James K Crocker; Jin Aun Ng; Paul J Keall; Jeremy T Booth
Journal:  Phys Med Biol       Date:  2012-04-20       Impact factor: 3.609

Review 6.  Reducing rectal injury during external beam radiotherapy for prostate cancer.

Authors:  Riccardo Valdagni; Tiziana Rancati
Journal:  Nat Rev Urol       Date:  2013-05-14       Impact factor: 14.432

7.  Parametrized rectal dose and associations with late toxicity in prostate cancer radiotherapy.

Authors:  Lynsey J Hamlett; Andrew J McPartlin; Edward J Maile; Gareth Webster; Ric Swindell; Carl G Rowbottom; Ananya Choudhury; Adam H Aitkenhead
Journal:  Br J Radiol       Date:  2015-08-06       Impact factor: 3.039

Review 8.  Target margins in radiotherapy of prostate cancer.

Authors:  Slav Yartsev; Glenn Bauman
Journal:  Br J Radiol       Date:  2016-07-20       Impact factor: 3.039

Review 9.  A narrative review of MRI acquisition for MR-guided-radiotherapy in prostate cancer.

Authors:  Jing Yuan; Darren M C Poon; Gladys Lo; Oi Lei Wong; Kin Yin Cheung; Siu Ki Yu
Journal:  Quant Imaging Med Surg       Date:  2022-02

10.  Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer.

Authors:  Jeroen Houben; Gill McColl; Johannes Ham Kaanders; Robert J Smeenk
Journal:  Clin Transl Radiat Oncol       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.